Published in Women's Health Weekly, May 31st, 1999
Women who underwent laparoscopic surgery for stage III-IV endometriosis were randomized postoperatively to receive either danazol 600 mg/day for three months or expectant management in a study by S. Bianchi, of the University of Milano, Italy, and colleagues ("Effects of Three Month Therapy with Danazol After Laparoscopic Surgery for Stage III/IV Endometriosis: A Randomized Study," Human Reproduction, May 1999;14(5):1335-1137).
Danazol showed similar...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly